Section 19-5-1151 - University of Arkansas for Medical Sciences National Cancer Institute Designation Trust Fund - Report(a) There is created on the books of the Treasurer of State, the Auditor of State, and the Chief Fiscal Officer of the State a trust fund to be known as the "University of Arkansas for Medical Sciences National Cancer Institute Designation Trust Fund".(b) The fund shall consist of:(1) Moneys obtained from private grants or other sources that are designated to be credited to the fund; and(2) Any other funds authorized or provided by law.(c) The fund shall be used by the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences solely to achieve and maintain status as a National Cancer Institute-Designated Cancer Center.(d) The Treasurer of State shall invest the moneys available in the fund.(e)(1) The investment of funds under this section is exempt from § 19-3-518(a)(2)(B)(i)(b) and (c).(2) Moneys in the fund may be invested in any instrument: (A) Listed in § 19-3-518(b)(1)(B); and(B) Approved by the guidelines established by the State Treasury investment policy approved by the State Board of Finance.(f) Moneys remaining in the fund at the end of each fiscal year shall carry forward and be made available for the purposes stated in this section in the next fiscal year.(g)(1) The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences shall submit a semiannual report containing the following information to the Governor; the Legislative Council or, if the General Assembly is in session, the Joint Budget Committee; the Senate Committee on Public Health, Welfare, and Labor; and the House Committee on Public Health, Welfare, and Labor:(A) The balance of the fund as of the reporting date;(B) A list of the administrative costs paid for from the fund, including without limitation salaries, pensions, and packages;(C) The total revenue received by the fund during the reporting period; and(D) A detailed description of the steps taken and the progress made toward achieving status as a National Cancer Institute-Designated Cancer Center during the reporting period.(2) The semiannual report required under this subsection shall be submitted by January 1 and July 1 of each year.Added by Act 2019, No. 181,§ 2, eff. 7/24/2019.